Why the federal government has bought 300,000 doses of a COVID-treating pill that hasn't been approved yet
Merck's COVID treatment drug, Molnupiravir, has only passed the first hurdle towards approval in Australia but the federal government has bought 300,000 doses after some promising preliminary results.
0 Response to "Why the federal government has bought 300,000 doses of a COVID-treating pill that hasn't been approved yet"
Post a Comment